|
The Lancet Infectious Diseases
| |
ISSN: 1473-3099
Imprint: ELSEVIER
The Lancet Infectious Diseases is recognized for providing a global, authoritative and independent forum for the highest
quality infectious diseases research and opinion, covering the research and treatment of diseases and conditions such as HIV/AIDS, healthcare
association infections, antibiotic resistance, malaria, tuberculosis, and emerging infections. ... click here for full Aims & Scope
The Lancet Infectious Diseases is recognized for providing a global, authoritative and independent forum for the highest
quality infectious diseases research and opinion, covering the research and treatment of diseases and conditions such as HIV/AIDS, healthcare
association infections, antibiotic resistance, malaria, tuberculosis, and emerging infections.
The Lancet Infectious Diseases
publishes original research, reviews, personal views, commentaries, and news across the global field of infectious disease. The journal
is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research
is fast-tracked to publication within weeks of submission and published first online on TheLancet.com before the print issue.
With
an impact factor of 16.14*, the journal ranks highest among the world's leading infectious diseases journals and has maintained this
leading position every year since the journal was ranked for the first time with the 2004 Journal Citation Reports.
Visit  www.TheLancet.com to find out more about The Lancet Infectious Diseases.
* 2010 Journal Citation Reports,
Thomson Reuters© 2011
Hide Aims & Scope
Editor: Contact the Editor
John McConnell
|
|
